Molecular, biological, and preliminary structural analysis of recombinant bryodin 1, a ribosome-inactivating protein from the plant Bryonia dioica

被引:20
作者
Gawlak, SL
Neubauer, M
Klei, HE
Chang, CYY
Einspahr, HM
Siegall, CB
机构
[1] BRISTOL MYERS SQUIBB PHARMACEUT RES INST,DEPT MOL IMMUNOL,SEATTLE,WA 98121
[2] BRISTOL MYERS SQUIBB PHARMACEUT RES INST,DEPT BIOCHEM,SEATTLE,WA 98121
[3] BRISTOL MYERS SQUIBB PHARMACEUT RES INST,MACROMOL CRYSTALLOG DEPT,PRINCETON,NJ 08543
关键词
D O I
10.1021/bi962474+
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bryonia dioica (Cucurbitaceae family) produces at least two type I ribosome-inactivating proteins, bryodin 1 (BD1) and bryodin 2 (BD2). A cDNA sequence encoding BD1 was isolated from B. dioica leaf mRNA using degenerative oligonucleotides and codes for a 22 amino acid signal peptide followed by a protein of 267 residues. Expression of two recombinant BD1 (rBD1) forms in Escherichia coli yielded proteins of 267 (to the natural stop codon) and 247 amino acids (to the putative cleavage site yielding the mature protein) that had identical protein synthesis inhibition activity as compared to native BD1. The substitution of Lys for Glu at position 189 near the active site reduced the ability of rBD1 to inhibit protein synthesis by 10-fold. Toxicologic analysis showed that rBD1 was well tolerated in rodents with LD(50) values of 40 mg/kg in mice and > 25 mg/kg in rats. A crystal of mature rBD1 protein was used to collect X-ray diffraction data to 2.1 Angstrom resolution. The rBD1 crystal structure was solved and showed extensive homology with other type I RIPs and A chains of type II RIPs. The studies described here demonstrate that rBD1 retains full biologic activity and serve as a guide for using this potent, yet nontoxic, RIP in the construction of single-chain immunotoxin fusion proteins.
引用
收藏
页码:3095 / 3103
页数:9
相关论文
共 39 条
[1]   RIBOSOME-INACTIVATING PROTEINS FROM PLANTS [J].
BARBIERI, L ;
BATTELLI, MG ;
STIRPE, F .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1154 (3-4) :237-282
[2]  
BARTHELEMY I, 1993, J BIOL CHEM, V268, P6541
[3]   TOXICITY OF, AND HISTOLOGICAL LESIONS CAUSED BY, RIBOSOME-INACTIVATING PROTEINS, THEIR IGG-CONJUGATES, AND THEIR HOMOPOLYMERS [J].
BATTELLI, MG ;
BARBIERI, L ;
STIRPE, F .
APMIS, 1990, 98 (07) :585-593
[4]   HIGH-SENSITIVITY OF CULTURED HUMAN TROPHOBLASTS TO RIBOSOME-INACTIVATING PROTEINS [J].
BATTELLI, MG ;
MONTACUTI, V ;
STIRPE, F .
EXPERIMENTAL CELL RESEARCH, 1992, 201 (01) :109-112
[5]   PROTEIN DATA BANK - COMPUTER-BASED ARCHIVAL FILE FOR MACROMOLECULAR STRUCTURES [J].
BERNSTEIN, FC ;
KOETZLE, TF ;
WILLIAMS, GJB ;
MEYER, EF ;
BRICE, MD ;
RODGERS, JR ;
KENNARD, O ;
SHIMANOUCHI, T ;
TASUMI, M .
JOURNAL OF MOLECULAR BIOLOGY, 1977, 112 (03) :535-542
[6]   T-CELL-TARGETED IMMUNOFUSION PROTEINS FROM ESCHERICHIA-COLI [J].
BETTER, M ;
BERNHARD, SL ;
WILLIAMS, RE ;
LEIGH, SD ;
BAUER, RJ ;
KUNG, AHC ;
CARROLL, SF ;
FISHWILD, DM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (25) :14951-14957
[7]  
BETTER M, 1994, J BIOL CHEM, V269, P9644
[8]   IMMUNOTOXINS AGAINST CANCER [J].
BRINKMANN, U ;
PASTAN, I .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1994, 1198 (01) :27-45
[9]   CRYSTALLOGRAPHIC R-FACTOR REFINEMENT BY MOLECULAR-DYNAMICS [J].
BRUNGER, AT ;
KURIYAN, J ;
KARPLUS, M .
SCIENCE, 1987, 235 (4787) :458-460
[10]   RIBBONS 2 0 [J].
CARSON, M .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1991, 24 :958-&